Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 4/10

vs
industry
vs
history
Cash to Debt 0.06
REMI's Cash to Debt is ranked lower than
55% of the 288 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.07 vs. REMI: 0.06 )
REMI' s 10-Year Cash to Debt Range
Min: 0   Max: No Debt
Current: 0.06

Equity to Asset 0.41
REMI's Equity to Asset is ranked higher than
57% of the 282 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.59 vs. REMI: 0.41 )
REMI' s 10-Year Equity to Asset Range
Min: -5.54   Max: 0.74
Current: 0.41

-5.54
0.74
F-Score: 6
Z-Score: -3.14
M-Score: -2.34
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 3/10

vs
industry
vs
history
Operating margin (%) -21.45
REMI's Operating margin (%) is ranked higher than
55% of the 287 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.64 vs. REMI: -21.45 )
REMI' s 10-Year Operating margin (%) Range
Min: -258.04   Max: 13.73
Current: -21.45

-258.04
13.73
Net-margin (%) 21.52
REMI's Net-margin (%) is ranked higher than
96% of the 287 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.99 vs. REMI: 21.52 )
REMI' s 10-Year Net-margin (%) Range
Min: -267.57   Max: 20.25
Current: 21.52

-267.57
20.25
ROE (%) 30.58
REMI's ROE (%) is ranked higher than
97% of the 278 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.72 vs. REMI: 30.58 )
REMI' s 10-Year ROE (%) Range
Min: -461.91   Max: 27.72
Current: 30.58

-461.91
27.72
ROA (%) 10.30
REMI's ROA (%) is ranked higher than
90% of the 289 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.08 vs. REMI: 10.30 )
REMI' s 10-Year ROA (%) Range
Min: -411.31   Max: 8.27
Current: 10.3

-411.31
8.27
ROC (Joel Greenblatt) (%) -38.89
REMI's ROC (Joel Greenblatt) (%) is ranked higher than
57% of the 288 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 20.54 vs. REMI: -38.89 )
REMI' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -5438.1   Max: 161.03
Current: -38.89

-5438.1
161.03
Revenue Growth (%) -40.90
REMI's Revenue Growth (%) is ranked lower than
52% of the 262 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.50 vs. REMI: -40.90 )
REMI' s 10-Year Revenue Growth (%) Range
Min: -50.4   Max: 61.4
Current: -40.9

-50.4
61.4
EBITDA Growth (%) 26.00
REMI's EBITDA Growth (%) is ranked higher than
91% of the 221 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.30 vs. REMI: 26.00 )
REMI' s 10-Year EBITDA Growth (%) Range
Min: -43.3   Max: 26
Current: 26

-43.3
26
» REMI's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Insider Trades

Latest Guru Trades with REMI

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)



No Guru Trades Found!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 10.30
REMI's P/E(ttm) is ranked higher than
97% of the 300 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 42.00 vs. REMI: 10.30 )
REMI' s 10-Year P/E(ttm) Range
Min: 4.8   Max: 240
Current: 10.3

4.8
240
P/B 2.50
REMI's P/B is ranked higher than
77% of the 300 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.38 vs. REMI: 2.50 )
REMI' s 10-Year P/B Range
Min: 1.14   Max: 65.83
Current: 2.5

1.14
65.83
P/S 2.10
REMI's P/S is ranked higher than
76% of the 300 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.74 vs. REMI: 2.10 )
REMI' s 10-Year P/S Range
Min: 0.22   Max: 8.03
Current: 2.1

0.22
8.03
EV-to-EBIT -13.05
REMI's EV-to-EBIT is ranked higher than
60% of the 300 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 29.42 vs. REMI: -13.05 )
REMI' s 10-Year EV-to-EBIT Range
Min: -280.8   Max: 52.8
Current: -13.05

-280.8
52.8
Current Ratio 0.88
REMI's Current Ratio is ranked lower than
54% of the 282 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.72 vs. REMI: 0.88 )
REMI' s 10-Year Current Ratio Range
Min: 0.11   Max: 3.7
Current: 0.88

0.11
3.7
Quick Ratio 0.73
REMI's Quick Ratio is ranked lower than
52% of the 282 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.85 vs. REMI: 0.73 )
REMI' s 10-Year Quick Ratio Range
Min: 0.03   Max: 3.07
Current: 0.73

0.03
3.07

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 2.50
REMI's Price/Tangible Book is ranked higher than
83% of the 300 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.44 vs. REMI: 2.50 )
REMI' s 10-Year Price/Tangible Book Range
Min: 1.43   Max: 48.33
Current: 2.5

1.43
48.33
Price/Median PS Value 1.90
REMI's Price/Median PS Value is ranked higher than
55% of the 300 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.19 vs. REMI: 1.90 )
REMI' s 10-Year Price/Median PS Value Range
Min: 0.25   Max: 5.17
Current: 1.9

0.25
5.17
Price/Graham Number 1.00
REMI's Price/Graham Number is ranked higher than
95% of the 300 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 6.70 vs. REMI: 1.00 )
REMI' s 10-Year Price/Graham Number Range
Min: 0.73   Max: 7.5
Current: 1

0.73
7.5
Earnings Yield (Greenblatt) -7.70
REMI's Earnings Yield (Greenblatt) is ranked higher than
55% of the 285 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.50 vs. REMI: -7.70 )
REMI' s 10-Year Earnings Yield (Greenblatt) Range
Min: -7.7   Max: 47.9
Current: -7.7

-7.7
47.9

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies
Compare: » details
Remedent, Inc. was originally incorporated under the laws of Arizona in September 1996 under the name Remedent USA, Inc. The Company designs, develops, manufactures and distributes cosmetic dentistry products. Its products are distributed in Europe, Asia, Middle East and the United States. It currently has three primary products: 'River 8' veneer, a 'prefab' veneer, Whitening Products and GlamSmile Veneers. The Company manufactures products in its facility in Ghent, Belgium, as well as through outsourced manufacturing in Ghent, China and France. As it markets dental products which are legally defined to be medical devices, it is considered to be a medical device manufacturer and as such it is subject to the regulations of, among other governmental entities, the United States Food and Drug Administration and the corresponding agencies of the states and foreign countries in which it sells its products.

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK